Since the onset of the COVID-19 pandemic a few months ago, the global COVID-19 diagnostics market is witnessing unparalleled growth in terms of revenue. The COVID-19 pandemic has been a life-altering event in human history as it has already claimed more than 207,000 lives and infected more than 2.97 million individuals globally. Since the COVID-19 has no therapeutic or preventive solution till date, testing is the only possible way currently to curb further spread of this infection. Companies have not only ramped up manufacturing of existing COVID-19 diagnostic products but are also conducting active research to introduce novel testing procedures, to further improve the efficiency & accuracy of these tests. The market for COVID-19 diagnostics is anticipated to be skyrocket in the coming months, as countries around the globe plan to amplify the number of tests being conducted significantly. The rapid spread of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be primarily attributed to the growth of the global COVID-19 diagnostics market. The principal objective behind testing is to prevent further transmission of the virus and isolate individuals suffering from the infection.
If testing, isolation, quarantining & social distancing norms are followed at an acceptable level, it would eventually segregate the infected population and restrict the further proliferation of the disease, till an effective therapeutic or preventive drug/vaccine is introduced. The diagnostic tests used to detect the COVID-19 includes molecular assays, serologic immunoassays and ancillary diagnostic tests. The molecular assay technique, which includes the RT-PCR-based assays, remains the cornerstone in COVID-19 diagnostic testing, owing to its high accuracy. However, serologic immunoassays which include rapid testing kits to detect antigens or antibodies, are gradually witnessing a surge in adoption. The growth of serological immunoassays can be attributed to the simple design of the kits which permits it to be mass-produced and make it widely available for community testing, or door-to-door testing. Moreover, the cost-effectiveness of these kits as compared to RT-PCR-based assays, are also playing a pivotal role in bolstering the growth of the serological immunoassay technique.
Major Key Players of the COVID-19 Diagnostics Market are:Seegene Inc., F. Hoffmann-La Roche Ltd, altona Diagnostics GmbH, SD BIOSENSOR, Abbott, BIOMEDOMICS INC., Bio-Rad Laboratories, Inc., VivaChek Biotech (Hangzhou) Co., Ltd., Sensing Self, PTE. Ltd, Thermo Fisher Scientific, PerkinElmer Inc., among others.
Read More @ http://www.sbwire.com/press-releases/covid-19-diagnostics-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-f-hoffmann-la-roche-seegene-abbott-1288935.htm
If testing, isolation, quarantining & social distancing norms are followed at an acceptable level, it would eventually segregate the infected population and restrict the further proliferation of the disease, till an effective therapeutic or preventive drug/vaccine is introduced. The diagnostic tests used to detect the COVID-19 includes molecular assays, serologic immunoassays and ancillary diagnostic tests. The molecular assay technique, which includes the RT-PCR-based assays, remains the cornerstone in COVID-19 diagnostic testing, owing to its high accuracy. However, serologic immunoassays which include rapid testing kits to detect antigens or antibodies, are gradually witnessing a surge in adoption. The growth of serological immunoassays can be attributed to the simple design of the kits which permits it to be mass-produced and make it widely available for community testing, or door-to-door testing. Moreover, the cost-effectiveness of these kits as compared to RT-PCR-based assays, are also playing a pivotal role in bolstering the growth of the serological immunoassay technique.
Major Key Players of the COVID-19 Diagnostics Market are:Seegene Inc., F. Hoffmann-La Roche Ltd, altona Diagnostics GmbH, SD BIOSENSOR, Abbott, BIOMEDOMICS INC., Bio-Rad Laboratories, Inc., VivaChek Biotech (Hangzhou) Co., Ltd., Sensing Self, PTE. Ltd, Thermo Fisher Scientific, PerkinElmer Inc., among others.
Read More @ http://www.sbwire.com/press-releases/covid-19-diagnostics-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-f-hoffmann-la-roche-seegene-abbott-1288935.htm
No comments:
Post a Comment